Cerebrovascular Diseases Extra

metrics 2024

Unlocking Innovations in Cerebrovascular Research

Introduction

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

Metrics 2024

SCIMAGO Journal Rank0.48
Journal Impact Factor2.00
Journal Impact Factor (5 years)2.00
H-Index21
Journal IF Without Self2.00
Eigen Factor0.00
Normal Eigen Factor0.10
Influence0.60
Immediacy Index0.70
Cited Half Life6.40
Citing Half Life7.60
JCI0.43
Total Documents165
WOS Total Citations422
SCIMAGO Total Citations845
SCIMAGO SELF Citations3
Scopus Journal Rank0.48
Cites / Document (2 Years)1.96
Cites / Document (3 Years)2.00
Cites / Document (4 Years)1.92

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #171/387
Percentile 55.81
Quartile Q2
Neurology (clinical) in Medicine
Rank #213/400
Percentile 46.75
Quartile Q3
Neurology in Neuroscience
Rank #111/192
Percentile 42.19
Quartile Q3

IF (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 55/96
Percentile 43.20
Quartile Q3

JCI (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 60/96
Percentile 37.50
Quartile Q3

Quartile History

Similar Journals

Journal of Korean Neurosurgical Society

Championing Research for Enhanced Patient Outcomes
Publisher: KOREAN NEUROSURGICAL SOCISSN: 2005-3711Frequency: 6 issues/year

The Journal of Korean Neurosurgical Society, with its ISSN 2005-3711 and E-ISSN 1598-7876, stands as a paramount resource in the field of neurosurgery, bridging clinical practice and cutting-edge research in both neurology and multidisciplinary neuroscience. Published by the Korean Neurosurgical Society, this open-access journal has been committed to disseminating invaluable knowledge to the global scientific community since its establishment in 1972. Located in Seoul, South Korea, the journal underscores its prominence with impressive quartile rankings—Q3 in Neurology (Clinical), Q3 in Neuroscience (Miscellaneous), and Q2 in Surgery for 2023. Its standing in Scopus rankings further emphasizes its impact, with a ranking of #195/551 in Medicine: Surgery and #235/400 in Medicine: Neurology (Clinical). By fostering a platform for innovative findings and advancements in surgical techniques, the Journal of Korean Neurosurgical Society aims to support professionals, researchers, and students alike in their pursuit of excellence and knowledge in neurosurgery and related fields, ensuring a brighter future for patient care and scientific inquiry.

Indian Heart Journal

Advancing Cardiac Knowledge for a Healthier Tomorrow
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

CURRENT PROBLEMS IN CARDIOLOGY

Exploring the Frontiers of Cardiac Research
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

NEUROLOGIC CLINICS

Connecting research and clinical excellence in neurology.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

NEUROLOGY

Advancing neurological science for a healthier tomorrow.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

Journal of Neurological Surgery Part A-Central European Neurosurgery

Pioneering insights for improved patient outcomes.
Publisher: THIEME MEDICAL PUBL INCISSN: 2193-6315Frequency: 6 issues/year

The Journal of Neurological Surgery Part A – Central European Neurosurgery is a prominent peer-reviewed publication dedicated to advancing the field of neurosurgery and its related disciplines. Published by THIEME MEDICAL PUBL INC and based in Germany, this journal has been a platform for critical advancements in clinical neurology and surgery since its inception in 2012, and it is set to continue through 2024. With a current impact factor reflecting its influence in the medical community, the journal ranks in the Q3 quartile across the categories of Medicine (miscellaneous), Neurology (clinical), and Surgery for 2023, ensuring a robust participation from the academic and medical professionals alike. It is indexed in Scopus, highlighting its global recognition, with rankings of #248/551 and #257/400 in the fields of Medicine & Surgery and Neurology, respectively. The journal features a range of open access options, thereby facilitating unrestricted dissemination of high-quality research to a wide audience. As a valuable resource, it aims to promote the exchange of innovative ideas and research findings that can contribute to clinical practice and improve patient outcomes in neurosurgery.

Stroke-Vascular and Interventional Neurology

Elevating standards in vascular interventions and stroke management.
Publisher: WILEYISSN: 2694-5746Frequency: 6 issues/year

Stroke-Vascular and Interventional Neurology, published by WILEY, is a leading open-access journal dedicated to advancing the field of neurology with a particular focus on stroke and vascular interventions. Since its inception in 2021 as an open-access journal, it has fostered a collaborative environment for researchers, clinicians, and educators to share innovative findings and clinical practices that address the complexities of cerebrovascular diseases. The journal emphasizes high-quality, peer-reviewed research articles, reviews, and case studies, providing critical insights into cutting-edge therapies and surgical techniques. With an ISSN of 2694-5746, it aims to support the global medical community in improving the diagnosis, treatment, and overall management of stroke patients. Researchers and healthcare professionals benefit from its accessible content, which is vital for fostering comprehensive understanding and evidence-based practices within the realm of interventional neurology.

Turkish Neurosurgery

Connecting Minds, Transforming Neurosurgical Care
Publisher: TURKISH NEUROSURGICAL SOCISSN: 1019-5149Frequency: 4 issues/year

Turkish Neurosurgery is a distinguished journal published by the TURKISH NEUROSURGICAL SOC, dedicated to advancing the field of neurosurgery and clinical neurology. With an ISSN of 1019-5149 and converging its focus from 1990 to 2024, this regional journal aims to bridge the gap in knowledge dissemination within Turkey and beyond. It holds a notable position in the academic community, categorized in the Q3 quartile for both Neurology (clinical) and Surgery in 2023, illustrating its relevance in these critical fields. Although currently not an open-access publication, it offers insights and research findings that are vital for researchers, practitioners, and students who seek to stay abreast of developments in neurosurgical practices. Located in Ankara, Turkiye, Turkish Neurosurgery provides a platform for sharing rigorous research that enhances clinical outcomes and informs surgical techniques, thus playing a crucial role in elevating the standards of neurosurgery in the region.

NEUROLOGIST

Enhancing Clinical Practice with Groundbreaking Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1074-7931Frequency: 6 issues/year

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

CEREBROVASCULAR DISEASES

Innovating treatment strategies for cerebrovascular disorders.
Publisher: KARGERISSN: 1015-9770Frequency: 6 issues/year

CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.